Global Hunter Securities Starts Swift Energy (SFY) at Buy; Prepare for Production Growth
Get Alerts SFY Hot Sheet
Price: $151.78 +0.42%
Rating Summary:
7 Buy, 7 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
7 Buy, 7 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Global Hunter Securities initiates coverage on Swift Energy (NYSE: SFY) with a Buy. PT $52.00.
Global analyst says, "For the past four years, Swift Energy's annual production has been declining. However, the company has re-focused its mission and put together a talented technical team ready to begin a new era of growth at Swift. We believe the company is turning the corner and is set for high production growth from its world-class portfolio of liquids-rich opportunities in Texas and Louisiana."
"While the market apparently is not recognizing the coming production growth at Swift, we think it will be hard to ignore as it begins flowing through the income statement in 4Q11."
For more ratings news on Swift Energy click here and for the rating history of Swift Energy click here.
Shares of Swift Energy closed at $26.39 yesterday.
Global analyst says, "For the past four years, Swift Energy's annual production has been declining. However, the company has re-focused its mission and put together a talented technical team ready to begin a new era of growth at Swift. We believe the company is turning the corner and is set for high production growth from its world-class portfolio of liquids-rich opportunities in Texas and Louisiana."
"While the market apparently is not recognizing the coming production growth at Swift, we think it will be hard to ignore as it begins flowing through the income statement in 4Q11."
For more ratings news on Swift Energy click here and for the rating history of Swift Energy click here.
Shares of Swift Energy closed at $26.39 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Faeth Therapeutics (FTH) at Buy
- William Blair Starts Tandem Diabetes Care (TNDM) at Outperform
- BMO Capital Starts Broadcom Limited (AVGO) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share